Clayton Eye Center

Morrow, Georgia 30260

0 studies enrolling now · 18 studies all time

What they study most

Ametropia, Dry Eye, Dry Eye Syndromes, Keratoconjunctivitis Sicca, Meibomian Gland Dysfunction, Myopia, Ocular Hypertension, Ocular Infections, Irritations and Inflammations, Open Angle Glaucoma, Open-Angle Glaucoma, Presbyopia, Primary Open-Angle Glaucoma

Studies at this site

• A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia — Completed
• Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation — Completed
• A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia — Completed
• A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia — Completed
• Dose-Ranging Study of the Bimatoprost Ocular Insert — Completed
• Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure — Completed
• An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert — Completed
• An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product — Completed
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension — Completed
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure — Completed
• Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older — Completed
• A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma — Completed
• Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers — Completed
• To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca — Completed
• Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights). — Completed
• Comparison of Two Toric Contact Lenses on Current Toric Wearers — Completed
• A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days — Completed
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006) — Completed